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INTRODUCTION
Most control programs for bovine tuberculosis include reporting to both veterinary and public
health authorities, and measures to prevent transmission from animals to humans. On the other
hand, reporting of human cases to veterinary authorities is rare, unless an animal source is suspected.
Exchange of data and strategic discussions between veterinary and public health authorities would
strengthen tuberculosis surveillance in both animal and human populations.
A One Health approach is clearly warranted for tuberculosis. The disease has similarly serious
consequences for humans and a broad range of animal species, and it has been strongly advocated
as a One Health issue (1). Yet, tuberculosis cases in humans and animals are commonly treated as
separate problems (2, 3).
Tuberculosis is caused by bacteria within the Mycobacterium tuberculosis complex (MTBC).
“Bovine tuberculosis” usually means infection in cattle with Mycobacterium bovis (3, 4). However,
this definition may be too restrictive, and the term bovine tuberculosis has been proposed to
signify infection in cattle with any bacteria in the MTBC (5, 6). Similarly, “human tubercu-
losis” usually refers to infection in humans with M. tuberculosis, while “zoonotic tuberculosis”
refers to human infection with M. bovis (7). However, for control and monitoring purposes,
as well as a One Health approach, it would be preferable to use the terms “human tubercu-
losis” and “bovine tuberculosis” for infection with all bacteria within the MTBC in humans
and cattle, respectively. Consequently, infections in other host species could be named after
the host species, complemented by specifying the infecting bacterial species. In the following,
the term “tuberculosis” is used for infection with bacteria within the MTBC, regardless of host
species.
TUBERCULOSIS IN DIFFERENT HOST POPULATIONS
Bacteria within the MTBC have a broad host range, although there are differences in host suscepti-
bility as well as in the detailed pathophysiology of the infection (4, 8, 9). Factors such as host species,
individual immunity, route of infection, and infectious dose have a strong impact on the course of the
disease, regardless of bacterial species (8, 10), and it may be difficult to discern the exact pathogenic
peculiarities of each species.
Differences in the infectious dose for a certain host species via a certain route are reflected in the
epidemiology of the disease in different populations (8, 10). In a high prevalence environment, the
probability of exposure and infection is high for any susceptible host as seen in sporadic cases or
outbreaks of tuberculosis in species, such as sheep, pigs, and horses.
Infection by M. bovis has been reported in a wide range of domesticated and wild animals.
Although not as frequent a cause asM. tuberculosis, a substantial number of humans with tubercu-
losis are infected withM. bovis. The prevalence ofM. bovis in human tuberculosis is generally higher
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in low-income regions with a high prevalence in cattle. However,
it has been proposed that the global prevalence of M. bovis in
humans is underestimated (11–15). In the absence of immuno-
suppression, human-to-human transmission of M. bovis is rare
but has been observed (15, 16).Mycobacterium caprae, previously
regarded as a caprine subtype of M. bovis, has also been identi-
fied as the causative agent of tuberculosis in domestic and wild
animals, as well as humans.
Mycobacterium tuberculosis is most commonly isolated from
people, but in regions with a high prevalence in the human
population, the infection may spill over to animals. Most animal
isolates of M. tuberculosis originate from cattle, pigs, dogs, and
Indian elephants, but the infection has also been demonstrated
in captive and free-living wildlife. Molecular epidemiology has
demonstrated transmission between humans and animals, in both
directions (17–20). Other MTBC species, such asMycobacterium
microti,Mycobacteriumpinnipedii, andMycobacteriumafricanum,
have also been isolated fromvarious host species. Genomic studies
into bacterial evolution suggest that sea mammals, in addition to
human dispersals, may have played a role in transmitting tuber-
culosis across the ocean in Pre-Columbian times, illustrating the
complexity of the host–pathogen relationship (21).
EPIDEMIOLOGY OF TUBERCULOSIS IN
DIFFERENT POPULATIONS
Infectious dose and route of infection are important factors
for the pathogenesis of the disease in individual hosts. Con-
sequently, population dynamics, spatial distribution, contact
patterns, and population sizes influence disease epidemiology.
Efforts to categorize host species as “maintenance hosts” and
“spillover hosts” are sometimes contradictory (8, 10, 22), prob-
ably due to the fact that the populations of these species differ
between regions and ecological systems. The maintenance pop-
ulation may consist of one or several host species, depending on
how the effective critical community size is achieved in different
ecosystems (23).
Detailed data, sufficient to demonstrate the epidemiology
of different MTBC species in different host populations, are
difficult to obtain. The epidemiology of the infection differs
regionally as well as within different populations in the same
region (8, 12, 24).
A crucial aspect of epidemiological data collection is case def-
inition. A case of human tuberculosis may be a patient with a
smear-positive sputum sample, a tuberculin reactor, a patient
from whom M. tuberculosis has been isolated, or a patient with
samples positive for any bacteria within the MTBC. Similarly,
animal cases may be defined as tuberculin reactors, animals
with visible lesions post mortem, animals with histological lesions
indicative of tuberculosis, or individuals with samples yieldingM.
bovis (or MTBC) in culture. Furthermore, the tuberculin test in
animals may be performed as a single or comparative test in the
skin of the neck or in the caudal fold, and the interpretation may
be different in different situations (e.g., regarding all inconclu-
sive reactions as positive, if a higher test sensitivity is prioritized
above specificity) (25). Different case definitions may be used for
different purposes, and this must be taken into account when
drawing conclusions from data.
OTHER ASPECTS AFFECTING
PREVALENCE FIGURES
Isolation of bacteria from each case would enable species
identification and molecular typing to support epidemiological
investigations. This is, however, not always feasible, and zoonotic
transmission (in either direction) of tuberculosis may be
overlooked.
In most regions of the world where the prevalence of tuber-
culosis in animals and humans is high, lack of resources means
that diagnostics are insufficient for bacterial identification to
species level. Even in high-income countries, diagnostics may
rely on microscopy of sputum smears, histological examination
of formalin-fixed tissue, culture on media not suitable for all
MTBC species, or the use of DNA probes unable to distinguish
between MTBC species (7, 13, 22). For example, the addition of
glycerol in culture media will enhance growth of M. tuberculosis
but inhibit growth of M. bovis, while culture media for M. bovis
should preferably include pyruvate (4, 13, 22). Most diagnostic
methods require some presumption about expected findings, and
this will affect diseasemonitoring across different populations and
geographical regions.
In the absence of bacteriological results, the clinical
presentation of tuberculosis cases is sometimes used as an
indicator of the causative agent. The primary manifestation ofM.
bovis in humans is usually extrapulmonary, but the proportion of
pulmonary cases appears to be increasing (12, 26). Occupational
exposure among farmers and abattoir workers usually leads to
aerosol infection, this type of exposure may be more frequent in
low-income countries with a high prevalence of tuberculosis in
animals but where detailed data are scarce (8, 10, 16, 22, 26, 27).
Site of infection is, therefore, not a solid basis for conclusions
about the causative agent.
WHAT IS IN A NAME?
Terminology affects risk perception and behavior (28), a fact
that is well known in the commercial world but not as com-
monly discussed in the scientific arena (29). The use of terms
like bovine and human tuberculosis would be better applied to
mean infection with MTBC in the respective host species. While
acknowledging the difference between the species within MTBC
and the need to identify each one in each case, it is important
not to let the definition of the disease lead to too narrow a
perspective, with possible lapses in tracing and control of the
infection. Despite public awareness campaigns to combat human
tuberculosis, knowledge of the risk presented by infected animals
and vice versa can be poor (30), perhaps reflecting a failure in
communication and or/awareness among the medical and vet-
erinary professions. The use of terms like “human tuberculosis”
and “zoonotic tuberculosis” (2, 3, 26) as contrasting events is
not helping disease control, although it may be seen as formally
correct.
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PUBLIC HEALTH AND
ANIMAL DISEASE CONTROL
The primary reason for tuberculosis control in animals is to pro-
tect public health. As cattle infected with members of the MTBC
can shed the bacteria in milk, unpasteurized dairy products rep-
resent a public health risk. In many parts of the world, milk is
heat-treated, but other dairy productsmay bemadewith rawmilk.
While pasteurization of all dairy products is crucial, tuberculosis
control in cattle and other animals remain important for human
and animal health (1, 10, 12, 22, 24). However, all stakeholders
may not support disease control efforts, which are perceived as
too costly and cumbersome, and therefore, not justifiable, when
milk is pasteurized anyway (31). There may be a risk that the
progress of tuberculosis control in animals, in combination with
pasteurization of milk, has made professionals in human and
veterinary medicine less aware, or even ignorant, of the fact that
tuberculosis does not restrict itself to one host population. A
stronger collaboration between veterinary and public health is
often called for, and this call for collaboration must be repeated
until taken for granted, and fully implemented in surveillance and
control activities.
Many of the most heavily infected regions in the world lack
the resources and infrastructure needed to control tuberculosis
in animals and humans, while the epidemiology may be entirely
different from what has been seen in countries where the disease
has been eradicated from the animal population (10, 12, 24). This
presents new challenges.
CONCLUSION
A systematic collaboration between different professions and con-
trol systems, and a common nomenclature clearly separating the
name of the host species from the infecting bacterial species
are the first steps toward effective tuberculosis surveillance and
control.
We should learn from history and not repeat the mistake of
those who, upon Koch’s discovery of different MTBC species,
first assumed that bovine tuberculosis did not affect humans,
leading to the pasteurization of milk for calves long before it
was applied to milk for human consumption. The more care-
ful attitude of some early scientists, proposing to omit the host
designation of the different bacterial species in order to antici-
pate assumptions that they are limited to the host whose name
they bear (32), should be remembered as we make scientific
progress. Understanding the complex ecosystem of the multi-
host pathogens within the MTBC is necessary for disease con-
trol. There is an urgent need for scientific advances in order to
meet the need for global tuberculosis control in all host popula-
tions, but this will require a new thinking as regards the ecology
of tuberculosis and a practical application of the One Health
concept.
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